2021 - The Year for EMH, page-431

First 431 Last

Share
Profile

Follow
CatmanRules

2,093 Posts.

606

14/03/21

17:08

Post #: 51755528
Share

Originally posted by Fingers xed: ↑

You are right Haplo , but i will disagree with one point particularly when the market compares Piedmont and EMH . Piedmont has a deal for spodumene with Tesla for 8,000 tonnes at $550 which is close to cost , total value $4.4 Million and has a $1.3 billion market cap . They still need to raise 100% of the whole project , so lots of dilution to come . EMH whilst it has 50 % of the project , the project is actually 10 to 20 times bigger and we now know we will get Free money ( Rodney Hooper $100 mil ) and then 70 % soft loans , so the maths is actually EMH need to raise 12 % of capex for 50 % of the project that is minimum 10 times bigger . Now when we get our first offtake , lets take Tesla 8,000 tonnes of Hydoxide , our sales value will be ( at $14,000 a tonne ) $112 Million compared to $4.4 million and EMH will have $40 million profit which is half share compared to Zero profit for Piedmont and their spodumene . The general market still generalises all lithium in one basket , this is one hurdle we need to overcome to get to a better valuation . I fully expect that we will actually surpass PLL market cap once the numbers are understood in comparison to PLL . The annual report for PLL at June 2020 showed a " consolidated " top 20 owning 73% , at same time EMH top 20 " Consolidated " owned aprox 85% . Based on the shortage of shares and a re-edducated market and more than probable 1 or two soon offtakes geater than the 8,000 tonnes of spod for PLL we will hit and hover at the $10 per share mark . Or $1.72 billionmarket cap . Just by KC indicating a move to Nasdaq proper indicates he thinks we will head to a $886 million market cap . There is lots more to be able to value , EMH , Their vision of more than 25% of 30 million cars is a massive incentive to invest in EMH future . And the fact Geomet will be rquired to share 70% of profits with their share holders in dividends . Massive rerate expected .

Expand

great post......Big week ahead is my call......Love my EMH and not selling a single share.....Hold on tight

EMH Price at posting: $1.69 Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

OJC

SPC to merge with Original Juice Co and Nature One Dairy

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 1,068 more messages in this thread...

First 431 Last

Add EMH (ASX) to my watchlist

(20min delay)
Last 16.0¢		Change 0.015(10.3%)		Mkt cap ! $33.19M

Open	High	Low	Value	Volume
15.5¢	16.5¢	15.5¢	$9.548K	59.19K

Buyers (Bids)

No.	Vol.	Price($)
1	30000	15.5¢

Sellers (Offers)

Price($)	Vol.	No.
18.0¢	23066	2

View Market Depth

No.	Vol.	Price($)
1	30000	0.155
2	200000	0.150
2	96161	0.145
4	37142	0.140
2	57414	0.135

Price($)	Vol.	No.
0.180	23066	2
0.195	10000	1
0.240	10670	1
0.000	0	0
0.000	0	0

Last trade - 15.51pm 02/10/2024 (20 minute delay)

EMH (ASX) Chart

2021 - The Year for EMH, page-431

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SPC to merge with Original Juice Co and Nature One Dairy

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

2021 - The Year for EMH, page-431

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SPC to merge with Original Juice Co and Nature One Dairy

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News